ZYNERBA PHARMACEUTICALS INC's ticker is ZYNE and the CUSIP is 98986X109. A total of 69 filers reported holding ZYNERBA PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is 1.05 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2018 | $160,000 | -1.2% | 16,450 | -11.7% | 0.02% | -4.8% |
Q1 2018 | $162,000 | -54.5% | 18,620 | -34.6% | 0.02% | -46.2% |
Q4 2017 | $356,000 | +49.6% | 28,470 | 0.0% | 0.04% | +44.4% |
Q3 2017 | $238,000 | -75.4% | 28,470 | -50.1% | 0.03% | -75.5% |
Q2 2017 | $968,000 | +5.6% | 57,070 | +25.1% | 0.11% | +2.8% |
Q1 2017 | $917,000 | +151.2% | 45,620 | +95.0% | 0.11% | +143.2% |
Q4 2016 | $365,000 | – | 23,395 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ETF MANAGERS GROUP, LLC | 2,679,457 | $20,257,000 | 0.73% |
Portolan Capital Management | 777,293 | $5,876,000 | 0.66% |
CAMPBELL CAPITAL MANAGEMENT INC | 110,451 | $835,000 | 0.62% |
ZEKE CAPITAL ADVISORS, LLC | 402,212 | $3,041,000 | 0.27% |
Leap Investments LP | 46,084 | $348,000 | 0.17% |
Bernardo Wealth Planning LLC | 26,419 | $199,000 | 0.14% |
Claraphi Advisory Network, LLC | 14,744 | $111,000 | 0.07% |
Sterling Investment Advisors, Ltd. | 11,000 | $83,000 | 0.04% |
A.R.T. Advisors, LLC | 81,372 | $615,000 | 0.03% |
Mirae Asset Global Investments Co., Ltd. | 544,408 | $4,116,000 | 0.03% |